Eva Maria Nothelfer

Summary

Affiliation: German Cancer Research Center
Country: Germany

Publications

  1. doi request reprint Identification and characterization of a peptide with affinity to head and neck cancer
    Eva Maria Nothelfer
    Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
    J Nucl Med 50:426-34. 2009
  2. doi request reprint Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals
    Regine Garcia Boy
    Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    Mol Imaging Biol 12:377-85. 2010
  3. doi request reprint The pharmacokinetics of cell-penetrating peptides
    Dikran Sarko
    Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany
    Mol Pharm 7:2224-31. 2010

Collaborators

Detail Information

Publications3

  1. doi request reprint Identification and characterization of a peptide with affinity to head and neck cancer
    Eva Maria Nothelfer
    Department of Nuclear Medicine, University of Heidelberg, Heidelberg, Germany
    J Nucl Med 50:426-34. 2009
    ..Targeted therapies, which enhance accumulation of the drug in the tumor, may be realized using tumor-specific binding peptides. This paper identifies and characterizes an HNSCC affine peptide...
  2. doi request reprint Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals
    Regine Garcia Boy
    Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
    Mol Imaging Biol 12:377-85. 2010
    ..This study investigates the characteristics of derivatives of the sunflower trypsin inhibitor 1 (SFTI-1), a 14 amino acid peptide with high intrinsic stability...
  3. doi request reprint The pharmacokinetics of cell-penetrating peptides
    Dikran Sarko
    Department of Nuclear Medicine, University Hospital Heidelberg, INF 400, 69120 Heidelberg, Germany
    Mol Pharm 7:2224-31. 2010
    ..In conclusion, CPPs are suitable as drug carriers for in vivo application provided that their pharmacokinetic properties are also considered in design of CPP drug delivery systems...